Anhui Fengyuan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Anhui Fengyuan Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥863.9M, which brings its debt-to-equity ratio to 42.7%. Its total assets and total liabilities are CN¥4.7B and CN¥2.6B respectively. Anhui Fengyuan Pharmaceutical's EBIT is CN¥141.4M making its interest coverage ratio 8.7. It has cash and short-term investments of CN¥241.4M.
Key information
42.7%
Debt to equity ratio
CN¥863.89m
Debt
| Interest coverage ratio | 8.7x |
| Cash | CN¥241.42m |
| Equity | CN¥2.02b |
| Total liabilities | CN¥2.64b |
| Total assets | CN¥4.66b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 000153's short term assets (CN¥2.0B) do not cover its short term liabilities (CN¥2.2B).
Long Term Liabilities: 000153's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥482.8M).
Debt to Equity History and Analysis
Debt Level: 000153's net debt to equity ratio (30.8%) is considered satisfactory.
Reducing Debt: 000153's debt to equity ratio has increased from 38.9% to 42.7% over the past 5 years.
Debt Coverage: 000153's debt is well covered by operating cash flow (22%).
Interest Coverage: 000153's interest payments on its debt are well covered by EBIT (8.7x coverage).